Lymphogranuloma venereum (LGV)
BASHH LGV 2013. Last updated: Dec 2013.
Article Last Updated:28/03/2026
Aetiology
LGV is an invasive STI caused by Chlamydia trachomatis serovars L1-L3, which causes more severe inflammation than the non-LGV serovars (A–K), covered in the Chlamydia article.
Clinical Features
Most UK cases are among MSM involved in dense sexual networks/party scene, not linked to LGV-endemic countries
There are 2 main presentations:
| Classic inguinal syndrome (heterosexual presentation) | Classic 3-stage progression:
|
| Anorectal syndrome (MSM presentation) | Primary manifestation: haemorrhagic proctitis
|
LGV should be suspected in the following patient (exam-rule):
- MSM + proctitis
- Painless genital ulcer + painful inguinal lymphadenopathy (unlike in syphilis; there is painless ulcer and painless lymphadenopathy)
Investigation and Diagnosis
Sample collection:
- Ulcer base exudate or from rectal mucosa
- Aspiration of lymph node or bubo
- Rectal and pharyngeal swabs from MSM and women exposed at those sites
- Urethral swab or first-catch urine specimen when urethritis and/or inguinal lymphadenopathy is present
Tests:
| NAAT | 1st line test:
|
| Rectal swab microscopy | Presence of polymorphonuclear leukocytes is predictive of LGV proctitis
Esp. in HIV +ve MSM |
| Other tests |
|
Management
Similar to those described in the Chlamydia article:
- 1st line: doxycycline for 21 days
- 2nd line: azithromycin or erythromycin
Reference